This inventor holds 24 USPTO granted patents and 2 published patent applications and 3 EPO patents, primarily in Cancer Therapeutics. Top assignees: Hoya Corporation, Honda Motor Co., Ltd., Saitama Medical University. Active years: 2011-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Iruma-gun, JP (2014)
- Sakura, JP (2018)
- Saitama, JP (2011 - 2020)
- Wako, JP (2019 - 2020)
Company Filing History:
11 out of 2,566 
8 out of 22,006 
5 out of 34 
Years Active: 2011-2020
Areas of Expertise:
Title: **Satoshi Inoue: A Pioneer in Nucleic Acid Research**
Introduction
Satoshi Inoue, based in Saitama, Japan, is a renowned inventor recognized for his significant contributions to the field of nucleic acid technology. With an impressive portfolio of 24 patents, Inoue's work primarily revolves around the development of innovative solutions for cancer treatment.
Latest Patents
Inoue's latest patents include groundbreaking research on double-stranded nucleic acid molecules designed to inhibit cancer cell growth and migration. These patents detail a double-stranded nucleic acid molecule aimed at suppressing the expression of non-coding RNA. The invention comprises a sense strand with a nucleotide sequence corresponding to specific target sequences, along with an antisense strand complementary to the sense strand, forming a stable double-strand structure. This innovative approach has the potential to significantly advance therapeutic strategies in oncology.
Career Highlights
Throughout his career, Satoshi Inoue has held prominent positions in esteemed organizations such as Hoya Corporation and Honda Motor Co., Ltd. His work has been pivotal in the advancement of molecular biology and therapeutic development, making him a key player in the industry.
Collaborations
Inoue has collaborated with notable contemporaries, including Shuichi Takeuchi and Tomoyoshi Koyama. These partnerships have led to fruitful research endeavors and have further established his reputation within the scientific community.
Conclusion
In summary, Satoshi Inoue stands out as a leading innovator in nucleic acid research, with a focus on addressing critical challenges in cancer treatment. His extensive patent portfolio and collaborative efforts underscore his influence and contributions to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile